Sensus Healthcare, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Sensus Healthcare, Inc. on May 27, 2025. The filing details the outcomes of four specific matters submitted to a vote by security holders.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes and Voting Results
The following matters were voted upon and approved by stockholders:
- Election of Director: Anthony Petrelli was elected as a Class I director for a three-year term expiring in 2028.
- For: 4,325,657
- Against: 1,563,543
- Abstention: 13,305
- Broker Non-Votes: 5,483,082
- Amendment of 2017 Incentive Plan: Stockholders approved an amendment to extend the plan's term and increase the number of issuable shares.
- For: 5,186,278
- Against: 495,719
- Abstention: 220,508
- Broker Non-Votes: 5,483,082
- Advisory Vote on Executive Compensation: Stockholders approved the 2024 compensation of named executive officers on a non-binding basis.
- For: 5,057,473
- Against: 346,796
- Abstention: 498,236
- Broker Non-Votes: 5,483,082
- Auditor Appointment Ratification: Stockholders ratified the appointment of Berkowitz Pollack Brant Advisors + CPAs, LLP as the independent registered public accountant for the fiscal year ending December 31, 2025.
- For: 11,113,695
- Against: 66,087
- Abstention: 205,805
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It strictly reports the tabulation of votes cast at the Annual Meeting.
Key Facts for Investor Verification
- Anthony Petrelli's re-election as a Class I director received significant support, though a notable portion of votes were cast against (approximately 26.6% of total votes cast excluding broker non-votes).
- The 2017 Incentive Plan was successfully amended to extend its term and increase share availability.
- The advisory vote on executive compensation passed with approximately 93.5% of votes cast in favor.
- Berkowitz Pollack Brant Advisors + CPAs, LLP was ratified as the auditor for the fiscal year ending December 31, 2025.
- Broker non-votes were significant for the director election and plan amendment but did not affect the outcome of the auditor ratification.